Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Santa Monica CA, La Jolla CA, Las Vegas NV,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase 1, Phase 2, Recruiting
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor
Location: Santa Monica CA, LA CA, Duarte CA, San Antonio TX,
Sponsor: ABL Bio, Inc.
Sex: All
Age: 18+
Code: NCT04762641
Phase 1, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Santa Monica CA, Los Angeles CA, Torrance CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for
Gastrointestinal Stromal Tumor (GIST),
Location: Santa Monica CA, Los Angeles CA, Orange CA, La Jolla CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06655246
Phase 1, Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for
Non Small Cell Lung Carcinoma, c-MET
Location: Santa Monica CA, Fullerton CA, Oxnard CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06772623
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Santa Monica CA, Duarte CA, Seattle WA, Calgary,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase 2, Recruiting
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: Santa Monica CA, Duarte CA, Dallas TX, Louisville KY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05685173
Phase 1, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Santa Monica CA, Los Angeles CA, Torrance CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Santa Monica CA, Los Alamitos CA, Fullerton CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase 1, Phase 2, Recruiting
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
for
Stomach Cancer Stage IV, Esophagus Cancer, Stomach Cancer
Location: Santa Monica CA, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07070466
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Santa Monica CA, Los Angeles CA, Duarte CA, Irvine CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase 1, Recruiting
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Santa Monica CA, Los Angeles CA, Duarte CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase 2, Phase 3, Recruiting
CRS Questionnaire Validation Project
for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: Santa Monica CA, Chicago IL, Toronto, Virginia City VA,
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases
Sex: All
Age: 18+
Code: NCT06970977
Recruiting
Starting Technology in At Risk Type 1 Diabetes Study
for
Diabetes Mellitus, Type 1
Location: Santa Monica CA, Torrance CA, Sylmar CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT06453928
Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for
Cancer Weight Loss
Location: Santa Monica CA, Los Angeles CA, Tucson AZ,
Sponsor: Endevica Bio
Sex: All
Age: 18+
Code: NCT06937177
Phase 2, Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Santa Monica CA, Orange CA, Salt Lake City UT,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05379985
Phase 1, Phase 2, Recruiting
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
for
Solid Tumor, Adult, Oncology
Location: Santa Monica CA, Huntersville NC
Sponsor: Trethera
Sex: All
Age: 18+
Code: NCT05055609
Phase 1, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
for
Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
Location: Santa Monica CA, Los Angeles CA, Duarte CA, Orange CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06858813
Phase 1, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Santa Monica CA, Duarte CA, La Jolla CA, Stanford CA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Santa Monica CA, Los Angeles CA, Duarte CA,